MRSi is pleased to accept abstract submissions from REI fellows, residents, and industry for our upcoming conference!
A limited number of abstracts will be accepted with fellows and residents receiving priority. To be considered for participation, you must fill out the below registration form and submit it to Coordinators@mrsmeeting.org. We look forward to your submission and seeing you at MRSi 2019!
The Midwest Reproductive Symposium international (MRSi) Program Committee invites you to submit a scientific abstract and poster to be considered for presentation at MRSi 2019. Abstracts must be submitted via email to Coordinators@mrsmeeting.orgwith the subject line "MRSi Abstraction Submission".
Fellow and Resident Deadline: Tuesday, April 2, 2019 at 5:00pm CST.
Industry Deadline: Monday, April 15, 2019 at 5:00pm CST.
If the nominating committee chooses your abstract, you will be invited to showcase your poster to conference attendees. Fellows and residents whose abstracts are accepted will have air or ground travel, hotel, and conference registration compensated. Abstracts submitted by industry will need to cover their own air/ground travel, hotel and conference registration. Two awards will be given: one to the top fellow/resident submission and the second to the overall top abstract (regardless of fellow, resident, or industry). The winner of each will give an oral presentation on Friday or Saturday, June 7th or 8th at MRSi 2019. If the fellow/resident winner also receives the overall top winning abstract, they will only do one oral presentation.
A limited number of abstracts will be accepted. To be considered for participation, you must fill out the below registration form and submit it to Coordinators@mrsmeeting.org.
Content - Abstracts must adequately describe the research performed so that the quality, originality, and completeness of the work can be evaluated. Abstracts submitted to previous conferences will only be accepted if they have been enhanced through the addition of new data, results, and/or interpretation. Only structured abstracts with the following headings can be submitted.
Objective: An introductory sentence indicating the objective and purpose of the study
Design: A briefly worded description of the study design
Materials and Methods: A description of experimental procedures including applicable statistical evaluation
Results: A summary of the new data and results
Conclusions: A statement of the study's conclusions
Support: Identify all sources of financial support for the research or state "None" if applicable.
Abbreviations used in abstracts must be defined. Abbreviations are permitted in titles if they immediately follow the term being abbreviated and are enclosed in parentheses. If used in the text, they should be defined at first mention if not already defined in the title.
ACCME guidelines require generic names be used for pharmaceuticals, biologics, and medical devices. The trade name of the particular product used in a study may be included in parentheses the first time the product is referenced. The trade name may be used if the product is the only one of its general type and use of the generic name would encumber the reader.
Limit the number of authors to six (6) - no exceptions.
In the abstract textboxes, list the presenting author first. Type each authors' first name, initial, last name and affiliation in upper and lower case, in italics, not in bold. The authors' names will be printed in the program exactly as submitted.
Do not identify individuals in the title or abstract body.
Bold the title and type it in all CAPS.
Abstract size limits - the body of the abstract is limited to 2000 characters, which may include one table. Inclusion of a table will replace some character space. Figures and/or graphics are not permitted and will be deleted. Titles are limited to 200 characters and are not included in the abstract body character count. Author names and affiliations are not included in either character count.
Review and selection of abstracts: Abstracts will be reviewed by the Program Nominating Committee and selected for inclusion in the program on the basis of scientific content and significance to the field of reproductive medicine.
Authors assume complete responsibility for the integrity and validity of the data at the time of submission.
For more information, please contact us at Coordinators@mrsmeeting.org.